For years, many providers stopped using hormone replacement therapy for menopause after a 2002 study showed there was a risk ...

I find myself fatigued from the news cycle lately, a precarious position to be in when I need to be writing about them every ...

Discover how the "Inner Courtroom" helps survivors of abuse reclaim power, voice, and meaning, turning trauma into healing ...

Mirum Pharmaceuticals (MIRM) is still unprofitable, but the company has managed to cut losses at a rate of 2.1% per year over the past five years. Looking ahead, analysts expect Mirum's earnings to ...

Psychic Sally has revealed what's in store for Jennifer Aniston and her new love Jim Curtis and if she thinks they'll go the ...

The 28-year-old British rock singer went viral with his salute to Ozzy Osbourne. Now he's trying to win over audiences on the ...

Author Jay Watkins' research offers proof of Richmond's rich queer history, especially in the world of theatre.

While investment has slowed in radiopharmaceuticals, analysts predict increased interest to come as Novartis shows just how successful radiopharmaceuticals can be.

Sarepta Therapeutics stock has seen its consensus analyst price target trimmed slightly, dropping from $22.88 to $21.55 per share in light of recent developments and research updates. This shift ...

Jelly Roll calls out Louis Vuitton Sydney, saying staff "looked" at him "like a criminal" during what should have been a ...

With travel providers building “retrograde-proof” packages, over 73% of Gen Z and 64% of millennials are seeking “spiritual” ...

The latest New York Fed credit report shows U.S. homeowners in strong financial health, with high equity and robust credit ...